Loading...
  • RNAi
  • RNAi therapeutics start acting when a short piece of double-stranded RNA (somewhere between 20 and 25 or so nucleotides) enters a cell. (asbmb.org)
  • Small Molecule
  • C4 Therapeutics is one of only a handful of companies working on tackling protein degradation using small-molecule binders--dubbed degronimids--that can target, destroy and clear proteins through the ubiquitin/proteasome system. (fiercebiotech.com)
  • In the context of Alzheimer's disease, the ultimate goal is to develop small molecule inhibitors, which could precisely decrease the production of amyloid," says Dr. Gerhard Multhaup, Chair of the Department of Pharmacology and Therapeutics at McGill and the study's senior author. (mcgill.ca)
  • researchers
  • As scientific researchers continue to investigate the complexities of the skin microbiome, our mission for the 2nd Microbiome Movement - Skin Health & Dermatology Summit is simple: Build a collaborative forum that unites forward thinking academic, dermatological & cosmetic researchers, and lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing solutions that modify the skin microbiome to treat disease (therapeutics) or support overall skin health (cosmetics). (news-medical.net)
  • develop
  • While the commercial availability of any new regenerative gingivitis treatments will mostly decide their potential of succeeding in the gingivitis diagnostics and therapeutics market, the way diagnosing technologies develop will also be a key determinant of the success of regenerative therapies. (tmrresearch.com)
  • health
  • Nevertheless, the increasing government initiatives regarding educating common masses about oral health are likely to bode well for the growth of the global gingivitis diagnostics and therapeutics market in the near future. (tmrresearch.com)
  • Global
  • The global market for gingivitis diagnostics and therapeutics is expected to witness growth at a significant rate in the next few years owing to factors such as the rising number of smokers, women of reproductive age, and obese people across the globe. (tmrresearch.com)
  • Thus, the increasing number of smokers across the world is providing a significant push to the global gingivitis diagnostics and therapeutics market. (tmrresearch.com)
  • companies
  • My recommendation to have a look at stocks of companies that are developing RNA therapeutics is hidden in comments #2 to 5 here. (fool.com)